title: Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection.
authors.affiliation: Department of Neurosciences, Reproductive and Odontostomatological Sciences, University Federico II, Via Pansini, 5, 80131, Naples, Italy. francesco.sacca@unina.it.
authors.forename: Francesco
authors.initials: F
authors.lastname: Saccà
authors.affiliation: Department of Neurosciences, Reproductive and Odontostomatological Sciences, University Federico II, Via Pansini, 5, 80131, Naples, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Pane
authors.affiliation: Department of Neurosciences, Reproductive and Odontostomatological Sciences, University Federico II, Via Pansini, 5, 80131, Naples, Italy.
authors.forename: Anna
authors.initials: A
authors.lastname: De Rosa
authors.affiliation: Department of Translational Medical Sciences, University Federico II, Naples, Italy.
authors.forename: Margherita
authors.initials: M
authors.lastname: Matarazzo
authors.affiliation: Department of Neurosciences, Reproductive and Odontostomatological Sciences, University Federico II, Via Pansini, 5, 80131, Naples, Italy.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Brescia Morra
mesh_terms: D000328:Adult; D005260:Female; D000068876:Fingolimod Hydrochloride / Q000627:therapeutic use*; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000150:complications / Q000188:drug therapy*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D000068876:Fingolimod Hydrochloride